Attenuation of Mouse Melanoma by A/C Magnetic Field after Delivery of Bi-Magnetic Nanoparticles by Neural Progenitor Cells
journal contributionposted on 28.12.2010 by Raja Shekar Rachakatla, Sivasai Balivada, Gwi-Moon Seo, Carl B. Myers, Hongwang Wang, Thilani N. Samarakoon, Raj Dani, Marla Pyle, Franklin O. Kroh, Brandon Walker, Xiaoxuan Leaym, Olga B. Koper, Viktor Chikan, Stefan H. Bossmann, Masaaki Tamura, Deryl L. Troyer
Any type of content formally published in an academic journal, usually following a peer-review process.
Localized magnetic hyperthermia as a treatment modality for cancer has generated renewed interest, particularly if it can be targeted to the tumor site. We examined whether tumor-tropic neural progenitor cells (NPCs) could be utilized as cell delivery vehicles for achieving preferential accumulation of core/shell iron/iron oxide magnetic nanoparticles (MNPs) within a mouse model of melanoma. We developed aminosiloxane−porphyrin functionalized MNPs, evaluated cell viability and loading efficiency, and transplanted neural progenitor cells loaded with this cargo into mice with melanoma. NPCs were efficiently loaded with core/shell Fe/Fe3O4 MNPs with minimal cytotoxicity; the MNPs accumulated as aggregates in the cytosol. The NPCs loaded with MNPs could travel to subcutaneous melanomas, and after A/C (alternating current) magnetic field (AMF) exposure, the targeted delivery of MNPs by the cells resulted in a measurable regression of the tumors. The tumor attenuation was significant (p < 0.05) a short time (24 h) after the last of three AMF exposures.